Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
FONAR Corp Market Cap
From what 0 stock analysts predict, the share price for FONAR Corp (FONR) might decrease by 100% in the next year. This is based on a 12-month average estimation for FONR. Price targets go from $ to $. The majority of stock analysts believe FONR is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
FONR is a stock in Healthcare which has been forecasted to be worth $ as an average. On the higher end, the forecast price is $ USD by from and on the lower end FONR is forecasted to be $ by from .
These are the latest 20 analyst ratings of FONR.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
1993
Staff Count
520
Country
United States
Sector/Industry
Healthcare/Diagnostics & Research
CEO
Mr. Timothy R. Damadian M.D.
Market Cap
$102.3M
In 2023, FONR generated $98.6M in revenue, which was a increase of 1.08% from the previous year. This can be seen as a signal that FONR's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 04 Dec 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - FONAR shows value potential with low debt, positive profitability, and a P/B ratio of 0.61. Q1-FY2025 earnings declined, yet book value grows from investments. Risks include low trading volume.
Why It Matters - FONAR's low P/B ratio and strong financials suggest potential upside despite recent earnings decline. Strategic investments could enhance future growth, making it a compelling value opportunity.
Wed, 13 Nov 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - FONAR's fiscal Q1 earnings show declining revenues and income due to lower patient fees and higher costs, despite modest growth in MRI scan volume.
Why It Matters - FONAR's revenue and income decline signals potential financial instability, raising concerns about profitability despite modest MRI volume growth, impacting investor confidence.
Tue, 12 Nov 2024
Sentiment - NEUTRAL
Source - Newsfile Corp
Summary - HMCA reported a 5% increase in MRI scan volume to 53,054 for Q3 2024. Cash and cash equivalents decreased 4% to $54.2 million compared to June 30, 2024.
Why It Matters - Increased MRI scan volume indicates growing demand and potential revenue growth, while the decline in cash reserves may raise concerns about liquidity and operational efficiency.
Mon, 30 Sep 2024
Sentiment - NEUTRAL
Source - Zacks Investment Research
Summary - FONAR's HMCA segment revenue growth is boosting its overall revenue for fiscal 2024.
Why It Matters - FONAR's revenue growth in the HMCA segment indicates strong demand, potentially boosting profitability and investor confidence in future performance.
Fri, 27 Sep 2024
Sentiment - NEUTRAL
Source - Newsfile Corp
Summary - HMCA reported an 11% increase in MRI scan volume to 209,327 for FY ending June 30, 2024, and a 10% rise in cash and cash equivalents to $56.3 million.
Why It Matters - Increased MRI scan volume and cash reserves indicate strong operational performance and financial health for HMCA, potentially enhancing investor confidence and stock value.
Tue, 16 Jul 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - FONAR Corporation has shown strong revenue and earnings growth, leading to a 'Buy' rating. Positive technical trends and SwiftMR adoption suggest ongoing profitability potential for shareholders.
Why It Matters - FONAR's revenue and earnings growth, coupled with a 'Buy' rating and strong fundamentals like SwiftMR adoption, signal potential long-term profitability and positive stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
